Is MiraLAX (polyethylene glycol 3350) appropriate for a 9-year-old child with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a 9-Year-Old Take MiraLAX?

Yes, MiraLAX (polyethylene glycol 3350) is safe and effective for treating constipation in 9-year-old children, despite the FDA label stating it should not be used in children. The evidence from pediatric guidelines and multiple clinical studies strongly supports its use in this age group.

Dosing for a 9-Year-Old Child

  • Start with 0.7-0.8 g/kg/day as the average effective maintenance dose, which translates to approximately 17-34 grams daily for most 9-year-olds (depending on weight) 1
  • Mix the powder in at least 4-8 ounces of liquid (water, juice, coffee, or tea) to ensure adequate osmotic activity 1, 2
  • Juices containing sorbitol provide a synergistic osmotic effect, making them particularly effective mixing liquids 1
  • The first bowel movement typically occurs within 2-4 days of starting therapy 3

Treatment Duration and Maintenance

  • Continue therapy for 1-2 weeks initially to achieve optimal effect, then maintain as needed 2, 3
  • Long-term use for 6-12 months or more is safe and effective in children, with studies showing an average treatment duration of 8.4 months 1
  • Do not stop abruptly once bowel movements normalize; continue maintenance dosing to prevent recurrence 1

Critical Implementation Points to Avoid Treatment Failure

  • Insufficient liquid volume is the most common cause of treatment failure - ensure the child drinks the full 4-8 ounces used for mixing 1, 2
  • Adequate daily fluid intake throughout the day is essential beyond just the mixing liquid, as PEG requires water to work osmotically 1, 2
  • If no bowel movement occurs after 3-4 days, add a bisacodyl suppository (10mg) or glycerin suppository while continuing PEG 1
  • For persistent constipation, consider adding an oral stimulant laxative (senna or bisacodyl) to the PEG regimen to exploit complementary mechanisms 2

Safety Profile in Children

  • Common side effects include abdominal distension, flatulence, nausea, bloating, and mild diarrhea - these are typically mild to moderate 2, 3
  • PEG has been proven safe in children as young as 1 month old, with a 97.6% success rate in relieving constipation 4, 5
  • No clinically significant changes in electrolytes, calcium, glucose, or renal function have been observed with chronic use 2
  • The only significant adverse effect is diarrhea, which resolves with dose adjustment 4, 6

Addressing the FDA Label Contradiction

The FDA label states "should not be used by children" 3, but this contradicts extensive pediatric evidence:

  • Multiple high-quality studies demonstrate safety and efficacy in children from infancy through adolescence 7, 4, 6, 8, 5
  • The American Gastroenterological Association and American Academy of Pediatrics endorse PEG as first-line therapy for pediatric constipation 1, 2
  • PEG is the most effective and safe therapy for both short and long-term treatment of pediatric functional constipation 8

When to Escalate Therapy

  • If constipation persists after 2 weeks of optimal PEG dosing with adequate hydration, increase the dose or add a stimulant laxative 2
  • Rule out fecal impaction before starting therapy, which may require manual disimpaction or enema first 1
  • Check for bowel obstruction or paralytic ileus before initiating therapy, as these are contraindications 1, 3

Adjunctive Lifestyle Measures

  • Increase dietary fiber only if the child has adequate fluid intake and physical activity 9
  • Encourage regular toileting habits, especially after meals 1
  • Ensure adequate daily fluid intake beyond the mixing liquid 1

References

Guideline

Pediatric Dosing of MiraLAX (Polyethylene Glycol 3350)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Polyethylene Glycol 3350 (MiraLAX) for Chronic Constipation – Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Polyethylene glycol for constipation in children younger than eighteen months old.

Journal of pediatric gastroenterology and nutrition, 2004

Research

Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation.

Canadian family physician Medecin de famille canadien, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.